ICYMI: Sanofi bets $8B on Regeneron to rebuild its drug pipeline #Sanofi #Regeneron
@quartzmedia.bsky.social
@quartzmedia.bsky.socialICYMI: Sanofi bets $8B on Regeneron to rebuild its drug pipeline #Sanofi #Regeneron
@quartzmedia.bsky.socialSanofi bets $8B on Regeneron to rebuild its drug pipeline #Sanofi #Regeneron
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump's plan to lower Medicare drug prices, a Lilly obesity drug, and more news.. statnews.com/pharmalot/20... #pharma #Trump #Medicare #obesity #weight #layoffs #FDA #animals #Lilly #Novo #AstraZeneca #Sanofi #Regeneron
@newsen.bsky.socialJoin the Upcoming Webinar on Transforming Research at Regeneron with Enhanced Scientific Intelligence #USA #New_York #Regeneron #Xtalks #Scientific_Intelligence
@pharmaphorum.bsky.social#Sanofi's long-running R&D #alliance with #Regeneron has gone up a gear with a #partnership – worth up to $8 billion – that spans four #newmedicines.
@forbes.it#Sanofi e #Regeneron ampliano l'alleanza sugli anticorpi: 1 miliardo di dollari subito, fino a 7 in più per quattro nuovi farmaci #accordi #anticorpi-monoclonali #biotecnologie #borsa #dupixent #farmaceutica #immunologia
@2k115.bsky.socialBreakout of the Sanofi-Regeneron deal structure: $1B upfront payment, up to $7B in contingent milestone payments, for a total potential value of $8B. Most of the capital deployment remains tied to clinical and commercial targets. #Pharma #Finance #Sanofi #Regeneron
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and more news.. www.statnews.com/pharmalot/20... #pharma #biotech #China #obesity #weight #antitrust #Russia #Teva #Regeneron
@newsen.bsky.socialDeadline Approaches for Lead Plaintiff in Regeneron Pharmaceuticals Lawsuit – Important Updates for Investors #United_States #New_York #Shareholders #Lawsuit #Regeneron